Gabapentin Enacarbil Post-marketing Clinical Study A Randomized, Double-blind, Placebo-controlled, Parallel-group Study in Subjects With Restless Legs Syndrome.
Phase of Trial: Phase IV
Latest Information Update: 06 Aug 2018
At a glance
- Drugs Gabapentin enacarbil (Primary)
- Indications Restless legs syndrome
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 26 Jul 2018 Status changed from active, no longer recruiting to completed.
- 11 Apr 2018 Planned number of patients changed from 360 to 375.
- 11 Apr 2018 Status changed from recruiting to active, no longer recruiting.